RSpace Blog

March 12, 2020

SnapGene integration brings support for molecular biologists

Integrations

Download attachment

associated with this post

From RSpace 1.68 we are pleased to be able to offer a new service to view DNA sequence files in collaboration with SnapGene. Currently supported file formats include:

  • Genbank (.gb, .gbk)
  • Fasta (.fa, .fasta)
  • Native Snapgene files (.dna)
  • Embl (.embl)
  • Lasergene (.seq)
  • SeqBuilder (.sbd)

You can:

  • View images of the files annotated with ORFs and restriction sites
  • View ORFs in a table
  • View restriction enzyme sites in a table
  • View and copy plain-text of the sequence for pasting into another application

Further details are described in the Help documentation here.

Rory Macneil

RSpace is an open-source platform that orchestrates research workflows into FAIR data management ecosystems: request a demo or contact us to learn more.

June 26, 2024

Research Space Embraces Open-Source to Empower FAIR Data Workflows

Open source

RSpace Opens its Research Data Management Platform to the Community

Read more

June 6, 2024

RSpace Solutions: Empowering Research Organizations with FAIR Data Workflows

Open source

In light of the upcoming open-source transition, we reflect on Research Space's services around RSpace tailored to enable research organisations as well as research cloud and research commons providers to implement, adopt, and maintain a secure, robust, and future-proof digital research data management environment.

Read more

April 19, 2024

Transitioning RSpace to Open-Source: Building a Community for a Journey Towards More Open Science and FAIR Data

Open source

We are looking forward to build an impactful open-source community around RSpace to increase interoperability between digital research solutions and facilitate the adoption of FAIR data workflows.

Read more

April 19, 2024

Research Space Announces Transition of RSpace to Open Source

News

We are excited to announce that RSpace will be transitioning to open-source in Q2 2024!

Read more